Finance & Accounting
Discover our Finance and Accounting case studies. The case studies are the work of internationally recognized authors from HEC Montréal and Wits Business School.
Showing 1–15 of 36 results
-
South African Budget 2019: Hard Choices in Tough Times
50,00 $CASE STUDY. Mboweni and his team had to find a way of putting the country on a path to fiscal sustainability, given the fiscal inheritance that his predecessors had left him.
-
The 2007/8 Global Financial Crisis: A Decade On
50,00 $CASE STUDY. While the general consensus was that the financial system had changed pursuant to 2008, as well as emerging stronger for all the changes that were made, the critical question remained – had it changed enough to prevent the events of 2007/8 repeating themselves?
-
South African Budget 2018: Walking a Fiscal Tightrope
50,00 $CASE STUDY. Finding a way of halting the decline of South Africa’s finances while ensuring that the fiscus continued in its central role of supporting the poor.
-
The South African National Minimum Wage Conundrum: Equality vs Growth?
50,00 $CASE STUDY. The South African government saw the national minimum wage (NMW) as a positive intervention that would address income inequality in the country and help to overcome poverty.
-
Peregrine Financial Group: Misappropriating Customer Funds
50,00 $CASE STUDY. In early July 2012, the United States Commodity Futures Trading Commission (CFTC) filed a federal lawsuit against Peregrine Financial Group In. c(PFG), a futures trading firm, and its founder Russell Wasendorf.
-
Charterhouse Bank: Banking Operations Undermining the Law
50,00 $CASE STUDY. On 23 June 2006, the Central Bank of Kenya (CBK) announced that it had placed Charterhouse Bank (Charterhouse) under statutory management as a result of an ongoing investigation into banking operations at Charterhouse.
-
Nomura Group: Trading with Privileged Information
50,00 $CASE STUDY. In late March 2012, the Securities Exchange and Surveillance Commission (SESC), the investigative unit of the Japanese Financial Services Authority (FSA), confirmed that Nomura Securities Co., Ltd (NSC) – a subsidiary of Nomura Holdings, Inc. – had been involved in insider trading.
-
Lehman Brothers: The Fall from Grace
50,00 $CASE STUDY. On 15 September 2008, Lehman Brothers Holdings Inc. filed for bankruptcy protection at the United States Bankruptcy Court in Manhattan, New York.
-
Deutsche Bank AG: Spying on Stakeholders
50,00 $CASE STUDY. In May 2009, news of Deutsche Bank’s spying operations became public. Over a period of six years, the bank’s corporate security department had conducted secret surveillance of certain employees, board members and shareholders.
-
Moral Bankruptcy and Trading Losses at Société Générale
50,00 $CASE STUDY. The purpose of this case is to generate discussion and learning on ethics and corporate governance.
-
Barclays Bank: Colluding to Manipulate LIBOR
50,00 $CASE STUDY. In late June 2012, the results of a long-term investigation by the United Kingdom’s (UK) financial watchdog, Financial Services Authorities (FSA), revealed that derivatives traders and bankers at Barclays bank had been colluding to influence submissions that influenced the London Interbank Offered Rate (LIBOR) and the European Interbank Offered Rate (EURIBOR).
-
Bank Saderat Iran: Financial Embezzlement under Sharia Law
50,00 $CASE STUDY. In September 2011, news of Bank Saderat Iran’s involvement in an embezzlement operation became public.
-
Standard Chartered Bank plc: Violating Banking Sanctions for Profit
50,00 $CASE STUDY. On 6 August 2012, Benjamin Lawsky, superintendent of the New York State Department of Financial Services (DFS), announced findings from an investigation of Standard Chartered Bank New York (SCBNY).
-
UBS AG: The Cost of Failing to Manage Operational Risk
50,00 $CASE STUDY. On 15 September 2011, news of United Bank of Switzerland’s (UBS) operational failures in its investment banking division hit the market.
-
Valeant Pharmaceuticals International, Inc.
8,00 $ – 50,00 $CASE STUDY. From 2008 to 2015, Valeant Pharmaceuticals International Inc. (Valeant) was a Wall Street darling under the leadership of CEO Michael Pearson. The company’s stock price soared as Pearson went on an acquisition spree.
Showing 1–15 of 36 results